COPD Journal of Chronic Obstructive Pulmonary Disease · 2018 · 19 citations · 18 references
MedicineClinical SciencesInternal MedicineInflammationPulmonary Function TestingPulmonologyChronic Obstructive Pulmonary DiseaseEosinophilic DisordersObstructive Lung DiseasePulmonary Function AssessmentPulmonary InflammationRespiratory DiseaseC-reactive Protein TestingChronic Obstructive Pulmonary Disease InflammationEosinophil-mediated InflammationEosinophilic Lung InflammationExacerbation Severity AssessmentExhaled Nitric OxideNitric OxideSystemic Inflammation Markers
; p < 0.05). A significant correlation between FeNO levels measured in ER and eosinophils was observed (r = 0.7; p < 0.001), but not at discharge or in stable phase. No significant association was found with parameters of systemic inflammation and mean stay. In conclusion, the determination of FeNO in AECOPD does not offer advantages over the evaluation of eosinophilia. These parameters rise at arrival in ER, descend at discharge, and remain unchanged in the stable phase. Both present similar diagnostic utility and are able to better identify the ACOS phenotype, which helps select a population that could benefit from a glucocorticoids therapy.
18
American Journal of Respiratory and Critical Care Medicine · 2005 · 3.2K citations
Raed A. Dweik, Peter B. Boggs, Serpil C. Erzurum et al. · American Journal of Respiratory and Critical Care Medicine · 2011 · 2.5K citations
Steven Pascoe, Nicholas Locantore, Mark T. Dransfield et al. · The Lancet Respiratory Medicine · 2015 · 733 citations
Mona Bafadhel, Susan McKenna, Sarah Terry et al. · American Journal of Respiratory and Critical Care Medicine · 2012 · 607 citations · Full text